Over-expression of the X-linked inhibitor of apoptosis protein (XIAP) delays serum deprivation-induced apoptosis in CHO-K1 cells.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 20547346)

Published in J Biosci Bioeng on March 29, 2010

Authors

Jane C J Liew1, Wen Siang Tan, Noorjahan Banu Mohamed Alitheen, Eng-Seng Chan, Beng Ti Tey

Author Affiliations

1: Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.

Articles by these authors

scFv antibody: principles and clinical application. Clin Dev Immunol (2012) 1.64

Recombinant Newcastle Disease virus capsids displaying enterovirus 71 VP1 fragment induce a strong immune response in rabbits. J Med Virol (2006) 0.97

Purification of bacteriophage M13 by anion exchange chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.90

Newcastle disease virus nucleocapsid protein: self-assembly and length-determination domains. J Gen Virol (2003) 0.88

Selection of high affinity ligands to hepatitis B core antigen from a phage-displayed cyclic peptide library. J Med Virol (2003) 0.87

BDMC33, A curcumin derivative suppresses inflammatory responses in macrophage-like cellular system: role of inhibition in NF-κB and MAPK signaling pathways. Int J Mol Sci (2012) 0.86

Virus-like particles of Macrobrachium rosenbergii nodavirus produced in bacteria. J Virol Methods (2011) 0.85

Mutagenesis of the nucleocapsid protein of Nipah virus involved in capsid assembly. J Gen Virol (2009) 0.84

Recombinant hepatitis B virus core particles: association, dissociation and encapsidation of green fluorescent protein. J Virol Methods (2008) 0.83

Purification and characterization of Nipah virus nucleocapsid protein produced in insect cells. J Clin Microbiol (2005) 0.83

Co-administration of avian influenza virus H5 plasmid DNA with chicken IL-15 and IL-18 enhanced chickens immune responses. BMC Vet Res (2012) 0.82

Detection of hepatitis B virus core antigen by phage display mediated TaqMan real-time immuno-PCR. J Virol Methods (2012) 0.81

Native agarose gel electrophoresis and electroelution: A fast and cost-effective method to separate the small and large hepatitis B capsids. Electrophoresis (2012) 0.81

Identification of epitopes in the nucleocapsid protein of Nipah virus using a linear phage-displayed random peptide library. J Med Virol (2005) 0.81

Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7. J Med Virol (2005) 0.81

Display of hepatitis B virus PreS1 peptide on bacteriophage T7 and its potential in gene delivery into HepG2 cells. J Virol Methods (2009) 0.81

Purification of His-tagged hepatitis B core antigen from unclarified bacterial homogenate using immobilized metal affinity-expanded bed adsorption chromatography. J Chromatogr A (2010) 0.81

Detection and phylogenetic profiling of nodavirus associated with white tail disease in Malaysian Macrobrachium rosenbergii de Man. Mol Biol Rep (2012) 0.80

Bioinformatics approaches for improved recombinant protein production in Escherichia coli: protein solubility prediction. Brief Bioinform (2013) 0.80

Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery. Mol Pharm (2012) 0.80

Cloning and expression of the nucleocapsid protein gene of nipah virus in different strains of Escherichia coli. J Biochem Mol Biol Biophys (2002) 0.79

Towards more accurate prediction of protein folding rates: a review of the existing Web-based bioinformatics approaches. Brief Bioinform (2014) 0.79

N-terminally His-tagged hepatitis B core antigens: construction, expression, purification and antigenicity. J Virol Methods (2009) 0.78

Statistical optimization of green fluorescent protein production from Escherichia coli BL21(DE3). Prep Biochem Biotechnol (2012) 0.78

Localization of the antigenic sites of newcastle disease virus nucleocapsid using a panel of monoclonal antibodies. Res Vet Sci (2008) 0.78

Single-step purification of the recombinant green fluorescent protein from intact Escherichia coli cells using preparative PAGE. Electrophoresis (2009) 0.78

Cell growth, cell-cycle progress, and antibody production in hybridoma cells cultivated under mild hypothermic conditions. Hybridoma (Larchmt) (2008) 0.78

Comparative evaluation of three purification methods for the nucleocapsid protein of Newcastle disease virus from Escherichia coli homogenates. J Microbiol (2005) 0.78

Production of the matrix protein of Nipah virus in Escherichia coli: virus-like particles and possible application for diagnosis. J Virol Methods (2009) 0.78

Display of the Viral Epitopes on Lactococcus lactis: A Model for Food Grade Vaccine against EV71. Biotechnol Res Int (2013) 0.78

Display of the VP1 epitope of foot-and-mouth disease virus on bacteriophage T7 and its application in diagnosis. J Virol Methods (2013) 0.78

Detection of virulent Newcastle disease virus using a phage-capturing dot blot assay. J Virol Methods (2006) 0.78

Characteristics of a phage effective for colibacillosis control in poultry. J Sci Food Agric (2012) 0.78

Interactions of hepatitis B core antigen and peptide inhibitors. J Med Chem (2007) 0.77

Pathotyping of Newcastle disease virus with a filamentous bacteriophage. Biotechniques (2004) 0.77

Purification of the extra-cellular domain of Nipah virus glycoprotein produced in Escherichia coli and possible application in diagnosis. J Biotechnol (2005) 0.77

Isolation and identification of lactic acid bacteria from fermented red dragon fruit juices. J Food Sci (2012) 0.77

Comparison of alginate and pectin based beads for production of poultry probiotic cells. J Biosci Bioeng (2011) 0.77

The direct recovery of recombinant hepatitis B core antigen from disruptate derived from continuous-flow bead milling. Biotechnol Appl Biochem (2008) 0.77

Purification of histidine-tagged nucleocapsid protein of Nipah virus using immobilized metal affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.76

Display of the antigenic region of Nipah virus nucleocapsid protein on hepatitis B virus capsid. J Biosci Bioeng (2011) 0.76

Synthesis and anti-microbial activity of hydroxylammonium ionic liquids. Chemosphere (2011) 0.76

A curcumin derivative, 2,6-bis(2,5-dimethoxybenzylidene)-cyclohexanone (BDMC33) attenuates prostaglandin E2 synthesis via selective suppression of cyclooxygenase-2 in IFN-γ/LPS-stimulated macrophages. Molecules (2011) 0.76

Detection and precipitation of hepatitis B core antigen using a fusion bacteriophage. J Gen Appl Microbiol (2005) 0.76

Nozzleless Fabrication of Oil-Core Biopolymeric Microcapsules by the Interfacial Gelation of Pickering Emulsion Templates. ACS Appl Mater Interfaces (2015) 0.76

A phage-displayed single chain variable fragment that interacts with hepatitis B core antigen: library construction, selection and diagnosis. J Clin Virol (2006) 0.75

Solution structure and in silico binding of a cyclic peptide with hepatitis B surface antigen. Chem Biol Drug Des (2013) 0.75

Structural analysis of peptides that interact with Newcastle disease virus. Peptides (2005) 0.75

Quantitation of green fluorescent protein using a gel-based imaging method. Anal Biochem (2008) 0.75

Purification of recombinant nucleocapsid protein of Newcastle disease virus from unclarified feedstock using expanded bed adsorption chromatography. Protein Expr Purif (2005) 0.75

Purification of long helical capsid of newcastle disease virus from Escherichia coli using anion exchange chromatography. Biotechnol Prog (2013) 0.75

Cloning and expression of the phosphoprotein gene of Newcastle disease virus in Escherichia coli. J Biochem Mol Biol Biophys (2002) 0.75

Short term and dosage influences of palm based medium- and long-chain triacylglycerols on body fat and blood parameters in C57BL/6J mice. Food Funct (2014) 0.75

Alginate-based emulsion template containing high oil loading stabilized by nonionic surfactants. J Food Sci (2014) 0.75

Municipal solid waste management at Taman Beringin Transfer Station in Malaysia. Waste Manag (2010) 0.75

A preparative purification process for recombinant hepatitis B core antigen using online capture by expanded bed adsorption followed by size-exclusion chromatography. J Microbiol Biotechnol (2009) 0.75

Heat treatment of unclarified Escherichia coli homogenate improved the recovery efficiency of recombinant hepatitis B core antigen. J Virol Methods (2006) 0.75

Purification of recombinant hepatitis B core antigen from unclarified Escherichia coli feedstock using phage-immobilized expanded bed adsorption chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.75

Direct purification of recombinant hepatitis B core antigen from two different pre-conditioned unclarified Escherichia coli feedstocks via expanded bed adsorption chromatography. J Chromatogr A (2007) 0.75

Purification of filamentous bacteriophage M13 by expanded bed anion exchange chromatography. J Microbiol (2004) 0.75

Effect of different operating modes and biomass concentrations on the recovery of recombinant hepatitis B core antigen from thermal-treated unclarified Escherichia coli feedstock. J Biotechnol (2008) 0.75

Fluorescent quantitation method for differentiating the nativity of green fluorescent protein. J Biosci Bioeng (2010) 0.75

Effects of environmental stresses and in vitro digestion on the release of tocotrienols encapsulated within chitosan-alginate microcapsules. J Agric Food Chem (2017) 0.75

Effects of process variables on the encapsulation of oil in ca-alginate capsules using an inverse gelation technique. J Microencapsul (2012) 0.75

An intensified esterification process of palm oil fatty acid distillate catalyzed by delipidated rice bran lipase. ScientificWorldJournal (2006) 0.75

Hepatitis B virus peptide inhibitors: solution structures and interactions with the viral capsid. Org Biomol Chem (2015) 0.75

Direct recovery of recombinant nucleocapsid protein of Nipah virus from unclarified Escherichia coli homogenate using hydrophobic interaction expanded bed adsorption chromatography. J Chromatogr A (2009) 0.75

Synthesis and anti-microbial potencies of 1-(2-hydroxyethyl)-3-alkylimidazolium chloride ionic liquids: microbial viabilities at different ionic liquids concentrations. Ecotoxicol Environ Saf (2012) 0.75